Bayer’s completion of its $63-billion acquisition of Monsanto, an agrochemical and seed company, fortifies the company’s plan of becoming a pure-play life-sciences company focused on...
In 2017, the FDA approved a record 1,027 abbreviated new drug applications, 843 of which were fully approved, and is working to further facilitate generic-drug development and approval....
